Kamla Pathak

Dr. Kamla Pathak


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2008 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MKMukesh Kumar
Mukesh Kumar
AMAmbikanandan Misra
Ambikanandan Misra
ABA.K. Babbar
A.K. Babbar
AMA.K. Mishra
A.K. Mishra
PMPuspa Mishra
Puspa Mishra
KPKamla Pathak
Kamla Pathak

1 December 2019 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
SJShweta Jain
Shweta Jain
VCVikash Chandra
Vikash Chandra
PJPankaj Kumar Jain
Pankaj Kumar Jain
KPKamla Pathak
Kamla Pathak
DPDevendra Pathak
Devendra Pathak
AVAnkur Vaidya
Ankur Vaidya
Among heterocyclic compounds, quinoline scaffold has become an important construction motif for the development of new drugs. Quinoline and its derivatives possess many types of biological activities and have been reported to show significant anticancer activity. Quinoline compounds play an important role in anticancer drug development as they have shown excellent results through different mechanism of action such as growth inhibitors by cell cycle arrest, apoptosis, inhibition of angiogenesis, disruption of cell migration and modulation. A number of quinoline derivatives have been reported till date for their anticancer activity. The present review, summarizes various mono-, di-, tri-, tetra- and heterocyclic substituent quinoline derivatives with potential anticancer activity. Their mechanism of action and possible structure activity relationship has also been discussed

1 January 2010 in Journal of Advanced Pharmaceutical Technology & Research
Verified
Journal Article
Open access
PDF file
PVPoonam Verma
Poonam Verma
KPKamla Pathak
Kamla Pathak
The main disadvantage of transdermal drug delivery is the poor penetration of most compounds into the human skin. The main barrier of the skin is located within its uppermost layer, the stratum corneum (SC). Several approaches have been developed to weaken this skin barrier. One of the approaches for increasing the skin penetration of drugs and many cosmetic chemicals is the use of vesicular systems, such as, liposomes and ethosomes. Ethosomes are phospholipid-based elastic nanovesicles containing a high content of ethanol (20-45%). Ethanol is known as an efficient permeation enhancer and has been added in the vesicular systems to prepare elastic nanovesicles. It can interact with the polar head group region of the lipid molecules, resulting in the reduction of the melting point of the stratum corneum lipid, thereby increasing lipid fluidity and cell membrane permeability. The high flexibility of vesicular membranes from the added ethanol permits the elastic vesicles to squeeze themselves through the pores, which are much smaller than their diameters. Ethosomal systems are much more efficient in delivering substances to the skin in the terms of quantity and depth, than either conventional liposomes or hydroalcoholic solutions. The scope of this small review is to introduce the novel concept of ethosomes and to describe some approaches and mechanisms of stimulating topical and transdermal products with ethosomes.

1 August 2011 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
RTRadheshyam Tiwari
Radheshyam Tiwari
KPKamla Pathak
Kamla Pathak

1 May 2012 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
PVPoonam Verma
Poonam Verma
KPKamla Pathak
Kamla Pathak

11 February 2015 in Clinical Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
KPKamla Pathak
Kamla Pathak
SRSmita Raghuvanshi
Smita Raghuvanshi